|  | Before adjustment | After adjustment | ||
---|---|---|---|---|---|
QoL score tested | ADT Duration | Estimate (95 % CI) | p | Estimate (95 % CI) | p |
Global health status | Long Term | −8 · 32 (−35 · 24 - 18 · 60) | 0 · 5134 | −2 · 92 (−69 · 57 - 63 · 73) | 0 · 9090 |
 | Short Term | 8 · 34 (−18 · 58 - 35 · 27) | 0 · 5123 | −1 · 71 (−68 · 84 - 65 · 41) | 0 · 9469 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Functional scales | Â | Â | Â | Â | Â |
Physical functioning | Long Term | 17 · 77 (−6 · 49 - 42 · 02) | 0 · 1364 | 24 · 77 (−53 · 63 - 103 · 16) | 0 · 4299 |
 | Short Term | 15 · 57 (−8 · 69 - 39 · 82) | 0 · 1873 | 7 · 43 (−71 · 52 - 86 · 38) | 0 · 8068 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Role functioning | Long Term | 20 · 36 (−15 · 89 - 56 · 6) | 0 · 2446 | 28 · 56 (−74 · 75 - 131 · 88) | 0 · 4855 |
 | Short Term | 42 · 59 (6 · 34 - 78 · 83) | 0 · 0250 | 46 · 35 (−57 · 7 - 150 · 40) | 0 · 2838 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Emotional functioning | Long Term | −7 · 81 (−26 · 65 - 11 · 03) | 0 · 3841 | −10 · 65 (−63 · 78 - 42 · 48) | 0 · 6074 |
 | Short Term | 15 · 56 (−3 · 28 - 34 · 39) | 0 · 0972 | 15 · 05 (−38 · 46 - 68 · 56) | 0 · 4784 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Cognitive functioning | Long Term | −27 · 76 (−42 · 84 - -12 · 67) | 0 · 0017 | −36 · 5 (−78 · 55 - 5 · 56) | 0 · 0736 |
 | Short Term | 16 · 68 (1 · 59 - 31 · 77) | 0 · 0330 | 13 · 39 (−28 · 97 - 55 · 74) | 0 · 4298 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Social functioning | Long Term | −0 · 02 (−22 · 83 - 22 · 78) | 0 · 9983 | −17 · 9 (−75 · 89 - 40 · 10) | 0 · 4399 |
 | Short Term | 22 · 21 (−0 · 59 - 45 · 02) | 0 · 0553 | 13 · 99 (−44 · 42 - 72 · 40) | 0 · 5423 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
 | Significance after Bonferroni correction for multiple testing was considered as p < 0·01 | ||||
Cancer Symptoms scales | Â | Â | Â | Â | Â |
Fatigue | Long Term | 0 · 34 (−39 · 62 - 40 · 31) | 0 · 9853 | −12 · 7 (−107 · 37 - 81 · 98) | 0 · 7285 |
 | Short Term | −18 · 52 (−58 · 49 - 21 · 44) | 0 · 3325 | 7 · 21 (−88 · 14 - 102 · 56) | 0 · 8440 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Nausea and vomiting | Long Term | 5 · 57 (−0 · 15 - 11 · 28) | 0 · 0554 | 4 · 63 (−8 · 94 - 18 · 20) | 0 · 3972 |
 | Short Term | 0 · 0 (−5 · 72 - 5 · 72) | 1 · 0000 | 0 · 8 (−12 · 87 - 14 · 47) | 0 · 8788 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Pain | Long Term | −14 · 43 (−36 · 64 - 7 · 78) | 0 · 1822 | 6 · 04 (−51 · 14 - 63 · 22) | 0 · 7839 |
 | Short Term | −16 · 67 (−38 · 88 - 5 · 54) | 0 · 1280 | −14 · 31 (−71 · 9 - 43 · 27) | 0 · 5281 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Insomnia | Long Term | 18 · 50 (−5 · 23 - 42 · 23) | 0 · 1152 | 39 · 7 (1 · 95 - 77 · 44) | 0 · 0432 |
 | Short Term | −3 · 70 (−27 · 43 - 20 · 03) | 0 · 7400 | 17 · 39 (−20 · 62 - 55 · 40) | 0 · 2729 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Constipation | Long Term | −0 · 01 (−33 · 53 - 33 · 51) | 0 · 9994 | −18 · 91 (−109 · 24 - 71 · 42) | 0 · 5923 |
 | Short Term | 5 · 54 (−33 · 77 - 44 · 84) | 0 · 7622 | −19 · 71 (−110 · 68 - 71 · 27) | 0 · 5800 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Diarrhoea | Long Term | −18 · 52 (−53 · 4 - 16 · 36) | 0 · 2698 | 8 · 58 (−25 · 92 - 43 · 09) | 0 · 5277 |
 | Short Term | −18 · 52 (−53 · 4 - 16 · 36) | 0 · 2698 | −4 · 34 (−39 · 09 - 30 · 41) | 0 · 7462 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Financial difficulties | Long Term | −14 · 81 (−43 · 53 - 13 · 91) | 0 · 2832 | −13 · 26 (−99 · 81 - 73 · 29) | 0 · 6925 |
 | Short Term | −14 · 81 (−43 · 53 - 13 · 91) | 0 · 2832 | −19 · 08 (−106 · 24 - 68 · 08) | 0 · 5762 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
 | Significance after Bonferroni correction for multiple testing was considered as p < 0·007 | ||||
Prostate cancer- specific symptoms scales | Â | Â | Â | Â | |
Urinary symptoms | Long Term | −1 · 49 (−27 · 72 - 24 · 74) | 0 · 9036 | 16 · 33 (−9 · 94 - 42 · 59) | 0 · 1595 |
 | Short Term | −14 · 82 (−41 · 05 - 11 · 41) | 0 · 2419 | 14 · 75 (−11 · 7 - 41 · 2) | 0 · 1965 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Bowel symptoms | Long Term | −10 · 74 (−27 · 3 - 5 · 81) | 0 · 1827 | 8 · 82 (−22 · 07 - 39 · 71) | 0 · 4721 |
 | Short Term | −5 · 18 (−21 · 73 - 11 · 38) | 0 · 5085 | −4 · 33 (−35 · 44 - 26 · 78) | 0 · 7188 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Hormonal treatment- related symptoms | Long Term | 24 · 81 (14 · 64 - 34 · 98) | 0 · 0002 | 36 · 12 (18 · 59 - 53 · 65) | 0 · 0046 |
Short Term | 3 · 71 (−6 · 46 - 13 · 88) | 0 · 4420 | −2 · 42 (−20 · 08 - 15 · 24) | 0 · 7230 | |
No ADT | 0 · 0 |  | 0 · 0 |  | |
Sexual interest | Long Term | −6 · 29 (−43 · 63 - 31 · 05) | 0 · 7200 | 10 · 64 (−71 · 4 - 92 · 68) | 0 · 7370 |
 | Short Term | −39 · 66 (−76 · 99 - -2 · 32) | 0 · 0392 | −10 · 9 (−93 · 52 - 71 · 73) | 0 · 7328 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
 | Significance after Bonferroni correction for multiple testing was considered as p < 0·0125 | ||||
Depression anxiety and stress symptoms scales | Â | Â | Â | Â | |
Depression | Long Term | 7 · 56 (4 · 51 - 10 · 60) | 0 · 0002 | 7 · 34 (2 · 01 - 12 · 67) | 0 · 0187 |
 | Short Term | −0 · 78 (−3 · 83 - 2 · 27) | 0 · 5886 | −0 · 96 (−6 · 33 - 4 · 41) | 0 · 6448 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Anxiety | Long Term | 2 · 22 (−0 · 44 - 4 · 88) | 0 · 0937 | 5 · 33 (0 · 24 - 10 · 43) | 0 · 0437 |
 | Short Term | −0 · 78 (−3 · 44 - 1 · 88) | 0 · 5359 | −1 · 64 (−6 · 77 - 3 · 48) | 0 · 4234 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
Stress | Long Term | 3 · 56 (−2 · 47 - 9 · 58) | 0 · 2225 | 5 · 90 (−9 · 44 - 21 · 24) | 0 · 3459 |
 | Short Term | −3 · 44 (−9 · 47 - 2 · 58) | 0 · 2364 | −1 · 41 (−16 · 86 - 14 · 04) | 0 · 8123 |
 | No ADT | 0 · 0 |  | 0 · 0 |  |
 | Significance after Bonferroni correction for multiple testing was considered as p < 0·017 |